Brokers Issue Forecasts for Vitalhub Corp.'s FY2025 Earnings (TSE:VHI)

Vitalhub Corp. (TSE:VHI - Free Report) - Cormark boosted their FY2025 earnings estimates for shares of Vitalhub in a research report issued on Monday, April 15th. Cormark analyst G. Fairweather now expects that the company will post earnings per share of $0.26 for the year, up from their previous forecast of $0.24. Cormark currently has a "Buy" rating and a $7.50 price target on the stock. The consensus estimate for Vitalhub's current full-year earnings is $0.15 per share.

Vitalhub (TSE:VHI - Get Free Report) last announced its quarterly earnings data on Thursday, March 21st. The company reported C$0.03 EPS for the quarter, missing the consensus estimate of C$0.04 by C($0.01). The firm had revenue of C$13.60 million for the quarter, compared to analysts' expectations of C$13.68 million. Vitalhub had a net margin of 8.66% and a return on equity of 5.78%.

Other equities analysts also recently issued research reports about the stock. Canaccord Genuity Group raised their price objective on shares of Vitalhub from C$5.25 to C$5.50 and gave the stock a "buy" rating in a report on Tuesday, February 6th. Eight Capital raised their target price on shares of Vitalhub from C$5.00 to C$6.25 and gave the company a "buy" rating in a report on Tuesday, February 6th.

Read Our Latest Analysis on VHI


Vitalhub Stock Up 5.8 %

Shares of TSE VHI traded up C$0.35 during trading on Tuesday, reaching C$6.35. 642,664 shares of the company traded hands, compared to its average volume of 171,319. The firm has a 50 day simple moving average of C$6.01 and a 200-day simple moving average of C$4.55. The stock has a market capitalization of C$277.56 million, a PE ratio of 63.50, a P/E/G ratio of 0.42 and a beta of 1.21. Vitalhub has a 52-week low of C$2.35 and a 52-week high of C$6.86.

About Vitalhub

(Get Free Report)

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.

Recommended Stories

Should you invest $1,000 in Vitalhub right now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: